Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Conavi Medical Corp V.TMD


Primary Symbol: T.TMD

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Bullboard Posts
Post by bayoubuckson Dec 16, 2014 11:05am
183 Views
Post# 23235485

Prototypes

PrototypesThis is the email I sent to IR 12/5/14.


I'm a relatively new share and warrant holder in Titan and have a question regarding the following statement in the latest MD&A.

 
As of September 30, 2014, the Company has completed its alpha commercial prototype as well as the initial round of tissue testing using components of the SPORT™ Surgical System. Titan remains on track to attain the next major milestone, the design and test of a feasibility prototype for the next generation console and instruments, in Q1 2015.


​ Can you tell me the difference in the alpha commercial prototype and the feasibility prototype?  If it's too complicated to explain by email, I would be glad to call for the explanation or you can call me at

No response to date.  Is anyone on the Board qualified to answer the question?
After this milestone, it's along time until the next one which IMO is why it's important.

Bullboard Posts